Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
414,415 A comparable result was also observed in a phase 2 trial (NCT02568839), which compared neoadjuvant T-DM1 monotherapy to the current standard treatment in HER2+ breast cancer
Rare side effects include mild soreness at injection site or temporary increased energy that may affect sleep if administered late in the day
Each herbal powder was extracted with water, concentrated, and vacuum-dried
Better vascularity supports sustained performance and localized metabolic efficiency
US$ 23.54
US$ 21.72
US$ 29.36
US$ 25.35
